Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ispecimen Inc. (ISPC:NASDAQ), powered by AI.
Ispecimen Inc. is currently trading at $0.13. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ispecimen Inc. on Alpha Lenz.
Ispecimen Inc.'s P/E ratio is -0.0.
“Ispecimen Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -191.5%.”
Ask for details →Ispecimen Inc. is a technology-driven biospecimen marketplace company focused on transforming the way healthcare researchers procure biological samples for advancing medical science. By utilizing its proprietary iSpecimen Marketplace platform, the company enables researchers to connect with a vast network of healthcare providers, leveraging existing clinical data to efficiently match sample requests. This process enhances the accessibility and streamlines the acquisition of human material, such as tissues, blood, and other biological samples, crucial for medical research and diagnostics development. Operating predominantly within the life sciences sector, Ispecimen Inc. plays a significant role in facilitating advancements in personalized medicine, diagnostics, and therapeutic development. Founded in 2009 and headquartered in Lexington, Massachusetts, the company not only supports research institutions but also contributes to the optimization of clinical specimen supply chains, thereby accelerating scientific discovery and innovation in the healthcare industry.
“Ispecimen Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -191.5%.”
Ask for details →Ispecimen Inc. (ticker: ISPC) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 24 employees. Market cap is $94,685.
The current price is $0.133 with a P/E ratio of -0.01x and P/B of 0.03x.
ROE is -191.51% and operating margin is -136.99%. Annual revenue is $9M.